Researchers aimed to systematically review the literature concerning the use of topical corticosteroids (TCS) in patients with atopic dermatitis (AD) and individuals with normal skin. They focused on whether the skin changes associated with AD could offer any protection against TCS-induced skin atrophy, a concern that often affects treatment adherence in AD patients.
Read more at the Journal of the American Academy of Dermatology International.